Join us as we celebrate the 25th Anniversary of ACI’s Annual Flagship Conference on Drug & Medical Device Litigation.

ACI’s Drug and Medical Device Litigation is truly the only event of its kind to stand the test of time. This conference has united the greatest minds of the pharmaceutical and medical device product liability defense bar for the last quarter century. Designed for masters-level strategy sharing and bringing together hundreds of industry leaders each year from both in-house, private practice and government, this is the only forum at which to gain essential winning life sciences product liability litigation strategies.

CONFIRMED IN-HOUSE SPEAKERS

Engage and Interact with Leading In-House Counsel from Top Drug & Device Companies


Patricia A. Barbieri

Patricia A. Barbieri

SVP, General Counsel and Secretary, Legal and Corporate Affairs
Daiichi Sankyo

Adam Bassing

Adam Bassing

Associate General Counsel, U.S. Litigation & Global Safety
UCB, Inc.

Candace Camarata

Candace Camarata

Associate General Counsel
Beckton, Dickinson and Company

Howard M. Cyr

Howard M. Cyr

Assistant General Counsel
Teleflex

Ashley Garry

Ashley Garry

Senior Legal Counsel
ArTara Therapeutics

Charna Gerstenhaber

Charna Gerstenhaber

Vice President, Head of Litigation & Investigations
Novartis Pharmaceuticals

Christopher Guth

Christopher Guth

Senior Assistant General Counsel
Bayer

Amy Todd Klug

Amy Todd Klug

Associate General Counsel, Litigation & Corporate Operations, Legal Affairs
Daiichi Sankyo, Inc.

Veronica M. Lei

Veronica M. Lei

Assistant General Counsel – Litigation and Legal Compliance
Eli Lilly and Company

Sarah Padgitt

Sarah Padgitt

Associate General Counsel
Baxter

Richard W. Silbert

Richard W. Silbert

VP, Chief Legal Strategist
Purdue Pharma L.P.

Matthew L. Stennes

Matthew L. Stennes

Vice President, Chief Litigation & Investigations Counsel
Medtronic

Carly W. Stephani

Carly W. Stephani

Principal Litigation Counsel, Litigation & Global Investigations
Medtronic

Sheea Sybblis

Sheea Sybblis

Associate General Counsel
Nestle Health Science

Brennan Torregrossa

Brennan Torregrossa

Senior Vice President, Head of Global Litigation
GSK

Learn from Renowned Jurists
Honorable Karen K. Caldwell

Honorable Karen K. Caldwell

Chief Judge
U.S. District Court, E.D. of Kentucky
Panel Judge
Judicial Panel on Multidistrict Litigation (JPML)

Honorable F. Dennis Saylor, IV

Honorable F. Dennis Saylor, IV

Chief Judge
U.S. District Court, D. Massachusetts

Honorable John R. Tunheim

Honorable John R. Tunheim

Chief Judge
U.S. District Court, D. Minnesota

Honorable Eduardo C. Robreno

Honorable Eduardo C. Robreno

Senior Judge
U.S. District Court, E.D. Pennsylvania

Honorable William F. Highberger

Honorable William F. Highberger

Superior Court Judge
Los Angeles County Superior Court

Honorable Rex Burlison

Honorable Rex Burlison

Circuit Judge
22nd Judicial Circuit of MO

What’s NEW for 2020?
Drug & Med Celebrates 25 Years

Industry leaders take a look back at the most significant legal and business developments that have impacted drug and device litigation in the last quarter century, as well as their implications and influence on future decisions, trends and strategies in this arena.

Covid-19’s Impact on Drug and Medical Device Litigation

A careful, comprehensive and timely analysis of the implications of Prep Act immunity on future drug and device litigation and an assessment of potential Covid-19 related MDLs.

Virtual Trial Practice Toolkit

Leading trial attorneys share strategies and best practices for conducting virtual/remote discovery, witness preparation, depositions, mediations, oral arguments and more.

Crisis Management Boot Camp

Lessons learned from Covid-19 on strengthening your response capabilities and minimizing business disruption in the face of a company or industry crisis.

MDL Case Study

Analysis of the unique nuances of three of 2020’s most significant MDLs – Hernia Mesh, Valsartan and Zantac.

Product Recall Do’s and Don’ts

Gain best practices for coordinating your team and minimizing damage to your company in the face of a nationwide product recall.

A View from the Bench — 2020 Edition

Judicial insights on how this year’s unprecedented events have impacted dockets, court functions, judicial proceedings and the JPML in general.

Special Focus Sessions

Advanced discussions surrounding this year’s changes to FDA approval processes as well as how current events are impacting juror mindsets, perceptions and verdicts in drug and device cases.

“5 Cs” of Successful In-House Counsel – Law Firm Partner Relationships

Join a unique conversation with our in-house counsel faculty designed to shed light on the expectations of in-house counsel from their law firm partners regarding cost, competency, communication, collaboration and culture.

High-Profile Prescription Drug and Medical Device Cases

In the last 10 years, nearly 300,000 product liability cases were filed in District Court, involving medical devices or pharmaceuticals products, including MDL-associated cases.

Join us this December to acquire firsthand insights from industry experts, and gain invaluable strategies to surmount the latest litigation challenges being faced by the drug and medical device products liability defense bar.

$4 BILLION

DEPUY ASR HIP

2013

$2.37 BILLION

ACTOS

2015

$1.4 BILLION

STRYKER REJUVENATE AND ABG II HIP IMPLANTS

2014

$1.2 BILLION

PREMPRO

2011

$775 MILLION

XARELTO

2019

$460 MILLION

AVANDIA

2010

$150 MILLION

ANDROGEL

2017

$110 MILLION

YASMIN

2012

$76 MILLION

RISPERDAL

2016

WHY ATTEND
Icon

450+

Attendees

Icon

10+

Esteemed Judges & Government Enforcers

Icon

25+

Companies on the Faculty & Advisory Board

Icon

3

Days of Networking

WHAT SETS US APART?
Conference Photo

Exceptional In-House
Participation

Your once-a-year opportunity to brainstorm with top in-house counsel including General Counsel and Chief Litigation Officers from diverse pharmaceutical and medical device companies and members of the products liability defense bar

Conference Photo

Strengthen Relationships & Establish New Connections

Network and brainstorm with the Who’s Who of the products liability defense bar from leading litigators in the field as well as from over 25 in-house counsel responsible for handling litigation on behalf of the country’s top life sciences companies

Conference Photo

The Most Relevant,
Forward-thinking Content

Join in high-level sessions focused on your most pressing challenges and opportunities

Conference Photo

Federal and State Judges and
Government Enforcers

Gain a 360 degree view of products liability litigation from all the key stakeholders

Over 450 attended the 2019 event, including representatives from such leading life sciences companies as:

  • Abbvie
  • Abiomed
  • Allergan
  • American Regent
  • Amneal Pharmaceuticals
  • AstraZeneca
  • Bausch Health
  • Bayer
  • Becton, Dickinson and Company
  • Biogen
  • Boehringer-Ingelheim
  • Bracco Diagnostics
  • Bristol-Myers Squibb
  • Cardinal Health
  • Carestream Health
  • Daiichi Sankyo
  • Eli Lilly & Co.
  • Endo Pharmaceuticals
  • Galderma
  • Genetech
  • GTI
  • GSK
  • Johnson & Johnson
  • LivaNova
  • Medtronic
  • Mylan
  • Novo Nordisk
  • Nuvasive
  • Olympus Corporation
  • PDL BioPharma
  • Pfizer
  • Purdue Pharma
  • Sage Therapeutics
  • Sandoz
  • Sanofi
  • Stryker Corporation
  • Teleflex
  • Teva Pharmaceuticals
  • Zimmer Biomet
  • UCB
  • W.L. Gore

See why 450+ professionals attend each year to network and discuss actionable strategies to surmount new litigation challenges.

View the 2019 Agenda and Speakers

Testimonials

Quote Icon

“There is no better forum for leading edge thinking on today’s most pressing drug and med litigation challenges.”

Director, Government Investigations
Merck & Co., Inc.

Quote Icon

“I enjoy attending ACI’s Drug and Med because of the quality presentations, and the interaction with the lawyers and clients that I’ve had the opportunity to work with for so many years.”

Goodell DeVries Leech & Dann LLP

Quote Icon

“The ACI Drug and Med conference is a great opportunity to connect with other members of the products liability bar and get real-time and real-world information about mass tort litigation throughout the country.”

Senior Counsel Litigation/Investigations

Quote Icon

“I attend ACI’s Drug and Med because it’s an opportunity to meet and reconnect with colleagues who are both my peers at other law firms and clients. I found the presentation on attorney advertising to be very helpful.”

DLA Piper LLP

Quote Icon

“Attending this conference is an opportunity to see both one’s clients as well as counsel from other firms with whom one works on a regular basis usually via email or phone but rarely in person, so you get to see these people at least once a year which is important.”

Mayer Brown LLP

Quote Icon

“ACI’s Drug and Med conference is informative and attracts top professionals year after year, giving you the opportunity to develop lasting professional and personal relationships.”

Danaher Lagnese PC
WHO YOU WILL MEET

In-house counsel for:

Pharmaceutical companies
Medical device companies
Biotech companies
Health care organizations

Attorneys practicing in:

Pharmaceuticals
Drug and medical devices
Products liability
Mass tort
Complex and multidistrict litigation healthcare


We hope to see you in December! Register early and save with the Early Bird discount today!

Register now

ACI’s Global Series of Life Sciences Conferences Bring together key sector stakeholders from around the globe to explore the most important trends impacting the many industries including pharmaceutical, biotechnology, medical device/diagnostic, and FDA-regulated consumer products. Our events cover every facet of legal and business relevance as well as controversy. Learn More

Can’t Join Us in Person?

Register for the livestream format and attend the conference from the comfort of your workplace or home.

Learn More